NVAX FY 2017 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M+103.1% YoY

Gross Profit

$31M100.0% margin

Operating Income

-$172M-550.8% margin

Net Income

-$184M-589.5% margin

EPS (Diluted)

$-12.56

Cash Flow

Operating Cash Flow

-$139M

Free Cash Flow

-$143M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$302M

Total Liabilities

$404M

Stockholders' Equity

-$102M

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$15M	+103.1%
Gross Profit	$31M	-$223M	+114.0%
Operating Income	-$172M	-$269M	+36.2%
Net Income	-$184M	-$280M	+34.4%